Apixaban versus warfarin in patients with atrial fibrillation

Granger, Christopher B., Alexander, John H., McMurray, John J.V., Lopes, Renato D., Hylek, Elaine M., Hanna, Michael, Al-Khalidi, Hussein R., Ansell, Jack +24 more·2011·New England Journal of Medicine
DOI 10.1056/nejmoa1107039

Cited by (1,013)

Items 101–200 of 1,013

  1. Biochemistry and biology of mammalian DNA methyltransferases
    A. Hermann, Humaira Gowher, Albert Jeltsch · 2004 · Cellular and Molecular Life Sciences
  2. New Antithrombotic Drugs
    Jeffrey Ian Weitz, John W. Eikelboom, Meyer Michel Samama · 2012 · CHEST Journal
  3. Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control
    Allan Cameron Skanes, Jeff S. Healey, John A. Cairns, Paul Dorian, Anne M. Gillis, Michael Sean McMurtry, L. Brent Mitchell, Atul Verma, Stanley Nattel · 2012 · Canadian Journal of Cardiology
  4. Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States
    Konstantinos C. Siontis, Xiaosong Zhang, Ashley Eckard, Nicole Martin Bhave, Douglas Earl Schaubel, Kevin He, Anca M. Tilea, Austin G. Stack, Rajesh Balkrishnan, Xiaoxi Yao et al. · 2018 · Circulation
  5. Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes
    Benjamin Adam Steinberg, Peter J. Shrader, Laine Elliott Thomas, Jack Ansell, Gregg C. Fonarow, Bernard John Gersh, Peter Russell Kowey, Kenneth W. Mahaffey, Gerald V. Naccarelli, James A. Reiffel et al. · 2016 · Journal of the American College of Cardiology
  6. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study
    Hijazi, Ziad, Oldgren, Jonas, Lindbäck, Johan, Alexander, John H, Connolly, Stuart J, Eikelboom, John W, Ezekowitz, Michael D, Held, Claes, Hylek, Elaine M, Lopes, Renato D et al. · 2016 · The Lancet
  7. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial
    Dans, Antonio L., Connolly, Stuart J., Wallentin, Lars, Yang, Sean, Nakamya, Juliet, Brueckmann, Martina, Ezekowitz, Michael, Oldgren, Jonas, Eikelboom, John W., Reilly, Paul A. et al. · 2013 · Circulation
  8. 2014 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation
    Atul Verma, John A. Cairns, L. Brent Mitchell, Laurent Macle, Ian Gilmour Stiell, David J. Gladstone, Michael Sean McMurtry, Stuart J. Connolly, Jafna L. Cox, Paul Dorian et al. · 2014 · Canadian Journal of Cardiology
  9. 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: Executive Summary
    Tze‐Fan Chao, Boyoung Joung, Yoshihide Takahashi, Toon Wei Lim, Eue‐Keun Choi, Yi‐Hsin Chan, Yutao Guo, Charn Sriratanasathavorn, Seil Oh, Ken Okumura et al. · 2021 · Thrombosis and Haemostasis
  10. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies: The SEARCH-AF study
    Lowres, Nicole, Neubeck, Lis, Salkeld, Glenn, Krass, Ines, McLachlan, Andrew J., Redfern, Julie, Bennett, Alexandra A., Briffa, Tom, Bauman, Adrian, Martinez, Carlos et al. · 2014 · Thrombosis and Haemostasis
  11. Non–Vitamin K Antagonist Oral Anticoagulant Dosing in Patients With Atrial Fibrillation and Renal Dysfunction
    Xiaoxi Yao, Nilay D. Shah, Lindsey R. Sangaralingham, Bernard John Gersh, Peter A. Noseworthy · 2017 · Journal of the American College of Cardiology
  12. Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation: A Report From the Swedish Atrial Fibrillation Cohort Study
    Friberg, Leif, Rosenqvist, Mårten, Lip, Gregory Y.H. · 2012 · Circulation
  13. XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation
    A. John Camm, Pierre Amarenco, Sylvia K. Haas, Susanne Hess, Paulus F. Kirchhof, Silvia Kuhls, Martin van Eickels, Alexander G.G. Turpie · 2015 · European Heart Journal
  14. Effect of Adherence to Oral Anticoagulants on Risk of Stroke and Major Bleeding Among Patients With Atrial Fibrillation
    Xiaoxi Yao, Neena S. Abraham, G. Caleb Alexander, William H. Crown, Víctor M. Montori, Lindsey R. Sangaralingham, Bernard John Gersh, Nilay D. Shah, Peter A. Noseworthy · 2016 · Journal of the American Heart Association
  15. Laboratory Measurement of the Anticoagulant Activity of the Non–Vitamin K Oral Anticoagulants
    Adam C. Cuker, Deborah M. Siegal, Mark Andrew Crowther, David A. Garcia · 2014 · Journal of the American College of Cardiology
  16. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH
    Karlyn A. Martin, Jan Beyer‐Westendorf, Bruce L. Davidson, Menno Volkert Huisman, Per Morten Sandset, Stephan Moll · 2016 · Journal of Thrombosis and Haemostasis
  17. Risk Profiles and Antithrombotic Treatment of Patients Newly Diagnosed with Atrial Fibrillation at Risk of Stroke: Perspectives from the International, Observational, Prospective GARFIELD Registry
    Ajay K. Kakkar, Iris Mueller, Jean‐Pierre Bassand, David Andrew Fitzmaurice, Samuel Zachary Goldhaber, Shinya Goto, Sylvia K. Haas, Werner Hacke, Gregory Y.H. Lip, Lorenzo Giovanni Mantovani et al. · 2013 · PLoS ONE
  18. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
    Piotr P. Ponikowski, Adriaan A. Voors, Stefan D. Anker, Héctor Bueno, John G.F. Cleland, Andrew J.S. Coats, Volkmar Falk, José Ramón González‐Juanatey, Veli‐Pekka Harjola, Ewa Anita Jankowska et al. · 2016 · Kardiologia Polska
  19. 2017 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients With Nonvalvular Atrial Fibrillation
    John U. Doherty, Ty J. Gluckman, William J. Hucker, James L. Januzzi, Thomas L. Ortel, Sherry J. Saxonhouse, Sarah A. Spinler · 2017 · Journal of the American College of Cardiology
  20. Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
    Torben Bjerregaard Larsen, Flemming Skjøth, Peter Brønnum Nielsen, Jette Nordstrøm Kjældgaard, Gregory Y.H. Lip · 2016 · BMJ
  21. The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation
    Hijazi, Ziad, Lindbäck, Johan, Alexander, John H., Hanna, Michael, Held, Claes, Hylek, Elaine M., Lopes, Renato D., Oldgren, Jonas, Siegbahn, Agneta, Stewart, Ralph A.H. et al. · 2016 · European Heart Journal
  22. Efficacy and Safety of Rivaroxaban Compared With Warfarin Among Elderly Patients With Nonvalvular Atrial Fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)
    Jonathan L. Halperin, Graeme J. Hankey, DANIEL M. WOJDYLA, Jonathan Paul Piccini, Yuliya V. Lokhnygina, Manesh R. Patel, GÜNTER E. BREITHARDT, Daniel E. Singer, Richard Clinton Becker, Werner Hacke et al. · 2014 · Circulation
  23. Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) Versus Warfarin in Patients With Atrial Fibrillation
    Corey Miller, Sonia Marzia Grandi, Avi Shimony, Kristian B. Filion, Mark Jeffrey Eisenberg · 2012 · The American Journal of Cardiology
  24. Dabigatran Association With Higher Risk of Acute Coronary Events
    Ken Uchino · 2012 · Archives of Internal Medicine
  25. Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
    Xiaoxi Yao, Neena S. Abraham, Lindsey R. Sangaralingham, Fernanda Bellolio, Robert D. McBane, Nilay D. Shah, Peter A. Noseworthy · 2016 · Journal of the American Heart Association
  26. The NCDR Left Atrial Appendage Occlusion Registry
    James V. Freeman, Paul D. Varosy, Matthew J. Price, David J. Slotwiner, Fred M Kusumoto, Chidambaram Rammohan, Clifford J. Kavinsky, Zoltan G. Turi, Joseph G. Akar, Cristina Koutras et al. · 2020 · Journal of the American College of Cardiology
  27. Percutaneous Left Atrial Appendage Suture Ligation Using the LARIAT Device in Patients With Atrial Fibrillation
    Krzysztof Bartuś, Frederick T. Han, Jacek Bednarek, Jacek Myć, Bogusław Kapelak, Jerzy Sadowski, Jacek Lelakowski, Stanisław Bartuś, Steven Joseph Yakubov, Randall J. Lee · 2012 · Journal of the American College of Cardiology
  28. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
    Marco Valgimigli, Héctor Bueno, Robert A. Byrne, Jean‐Philippe Collet, Francesco Costa, Anders Jeppsson, Peter Jüni, Adnan Kastrati, Philippe H. Kolh, Laura Mauri et al. · 2017 · European Journal of Cardio-Thoracic Surgery
  29. New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events
    Agon Mekaj, Ymer Mekaj, Shkelzen B. Duci, Ermira Miftari · 2015 · Therapeutics and Clinical Risk Management
  30. New Oral Anticoagulants Increase Risk for Gastrointestinal Bleeding: A Systematic Review and Meta-analysis
    Ingrid Lisanne Holster, Vera E. Valkhoff, Ernst Johan Kuipers, Eric T.T.L. Tjwa · 2013 · Gastroenterology
  31. Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial
    Ruff, Christian T, Giugliano, Robert P, Braunwald, Eugene, Morrow, David A, Murphy, Sabina A, Kuder, Julia F, Deenadayalu, Naveen, Jarolim, Petr, Betcher, Joshua, Shi, Minggao et al. · 2015 · The Lancet
  32. Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran
    Robert G. Hart, Hans‐Christoph Diener, Sean Yang, Stuart J. Connolly, Lars C. Wallentin, Paul A. Reilly, Michael D. Ezekowitz, Salim Yusuf · 2012 · Stroke
  33. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation
    Craig T. January, L. Samüel Wann, Hugh G Calkins, Lin Y. Chen, Joaquin E. Cigarroa, Joseph C. Cleveland, Patrick T. Ellinor, Michael D. Ezekowitz, Michael E. Field, Karen L. Furie et al. · 2019 · Heart Rhythm
  34. 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
    Gordon F. Tomaselli, Kenneth W. Mahaffey, Adam C. Cuker, Paul P. Dobesh, John U. Doherty, John W. Eikelboom, Roberta Florido, Ty J. Gluckman, William J. Hucker, Roxana Mehran et al. · 2020 · Journal of the American College of Cardiology
  35. Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) Trial Analysis
    Hijazi, Ziad, Hohnloser, Stefan H., Oldgren, Jonas, Andersson, Ulrika, Connolly, Stuart J., Eikelboom, John W., Ezekowitz, Michael D., Reilly, Paul A., Siegbahn, Agneta, Yusuf, Salim et al. · 2014 · Circulation
  36. Association Between Use of Non–Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation
    Shang‐Hung Chang, I‐Jun Chou, Yung‐Hsin Yeh, Meng‐Jiun Chiou, Ming‐Shien Wen, Chi-Tai Kuo, Lai‐Chu See, Chang‐Fu Kuo · 2017 · JAMA
  37. 2020 Clinical practice guidelines for Chronic heart failure
    Russian Society of Cardiology · 2020 · Russian Journal of Cardiology
  38. Challenges in the design and interpretation of Noninferiority trials
    Mauri, Laura, D’Agostino, Ralph B. · 2017 · New England Journal of Medicine
  39. Cortical superficial siderosis: detection and clinical significance in cerebral amyloid angiopathy and related conditions
    Charidimou, Andreas, Linn, Jennifer, Vernooij, Meike W., Opherk, Christian, Akoudad, Saloua, Baron, Jean-Claude, Greenberg, Steven M., Jäger, Hans Rolf, Werring, David J. · 2015 · Brain
  40. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex
    Anthony Carnicelli, Hwanhee Hong, Stuart J. Connolly, John W. Eikelboom, Robert Patrick Giugliano, David A. Morrow, Manesh R. Patel, Lars C. Wallentin, John Hunter Alexander, Maria Cecilia Bahit et al. · 2022 · Circulation
  41. Insights Into Onco-Cardiology
    Dimitrios T. Farmakis, John Parissis, Gerasimos S Filippatos · 2013 · Journal of the American College of Cardiology
  42. Secondary stroke prevention
    Graeme J. Hankey · 2013 · The Lancet Neurology
  43. Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation
    Francesco Dentali, Nicoletta Riva, Mark Andrew Crowther, Alexander G.G. Turpie, Gregory Y.H. Lip, Walter Ageno · 2012 · Circulation
  44. The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: Rationale and methods
    Hooman Kamel, W. T. Longstreth, David Tirschwell, Richard A. Kronmal, Joseph P. Broderick, Yuko Y. Palesch, Caitlyn Meinzer, Catherine Dillon, Irene Ewing, Judith A. Spilker et al. · 2018 · International Journal of Stroke
  45. Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial haemorrhage related to vitamin K antagonists (INCH): a randomised trial
    Thorsten Steiner, Sven Poli, Martin Griebe, Johannes Hüsing, Jacek Hajda, Anja Freiberger, Martin Bendszus, Julian Bösel, Hanne Christensen, Christian Dohmen et al. · 2016 · The Lancet Neurology
  46. Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation
    Riccardo Cappato, Michael D. Ezekowitz, Allan L. Klein, A. John Camm, Changsheng Ma, Jean‐Yves Le Heuzey, Mario R. Talajic, Maurício Scanavacca, Panos E. Vardas, Paulus F. Kirchhof et al. · 2014 · European Heart Journal
  47. Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial
    Sigrun Halvorsen, Dan Atar, H. Yang, Raffaele De Caterina, Çetin Erol, D. Garcia, Christopher Bull Granger, M. Hanna, Claes Held, Steen Husted et al. · 2014 · European Heart Journal
  48. JCS/JSCS/JATS/JSVS 2020 Guidelines on the Management of Valvular Heart Disease
    Chisato Izumi, Kiyoyuki Eishi, Kyomi Ashihara, Takeshi Arita, Yutaka Otsuji, Takashi Kunihara, Tatsuhiko Komiya, Toshihiko Shibata, Yoshihiro Seo, Masao Daimon et al. · 2020 · Circulation Journal
  49. Apixaban, an oral, direct factor X a inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects
    Charles E. Frost, Jessie J. Wang, Sunil Nepal, Alan E. Schuster, Yu Chen Barrett, Rogelio Mosqueda‐Garcia, Richard A. Reeves, Frank P. LaCreta · 2012 · British Journal of Clinical Pharmacology
  50. Parenteral anticoagulants in heart disease: Current status and perspectives (Section II)
    Steen Husted, Lars C. Wallentin, Felicita Andreotti, Harald Arnesen, F Bachmann, Colin Baigent, Kurt Huber, Jørgen Jespersen, Steen Dalby Kristensen, Gregory Y.H. Lip et al. · 2013 · Thrombosis and Haemostasis
  51. Variations in Cause and Management of Atrial Fibrillation in a Prospective Registry of 15 400 Emergency Department Patients in 46 Countries
    Jonas Oldgren, Jeff S. Healey, Michael D. Ezekowitz, Patrick Commerford, Álvaro Avezum, Prem S Pais, Jun Zhu, Petr Janský, Alben Sigamani, Carlos Arturo Morillo et al. · 2014 · Circulation
  52. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
    Michael Glikson, Rafael Wolff, Gerhard Hindricks, John M. Mandrola, A. John Camm, Gregory Y.H. Lip, Laurent Fauchier, Timothy R. Betts, Thorsten Lewalter, Jacqueline Saw et al. · 2020 · EuroIntervention
  53. Atrial fibrillation in heart failure: what should we do?
    Dipak Kotecha, Jonathan Paul Piccini · 2015 · European Heart Journal
  54. Interventional Spine and Pain Procedures in Patients on Antiplatelet and Anticoagulant Medications
    Samer Narouze, Honorio T. Benzon, David Anthony Provenzano, Asokumar Buvanendran, José Antonio De Andrés, Timothy Ray Deer, Richard L Rauck, Marc Alan Huntoon · 2015 · Regional Anesthesia & Pain Medicine
  55. Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
    Wonkyung Byon, Samira J. Merali, Rebecca A. Boyd, Charles E. Frost · 2019 · Clinical Pharmacokinetics
  56. Laboratory Assessment of the Anticoagulant Activity of Direct Oral Anticoagulants
    Bethany Samuelson Bannow, Adam C. Cuker, Deborah M. Siegal, Mark Andrew Crowther, David A. Garcia · 2016 · CHEST Journal
  57. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
    Peter Brønnum Nielsen, Flemming Skjøth, Mette Søgaard, Jette Nordstrøm Kjældgaard, Gregory Y.H. Lip, Torben Bjerregaard Larsen · 2017 · BMJ
  58. 2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
    Gordon F. Tomaselli, Kenneth W. Mahaffey, Adam C. Cuker, Paul P. Dobesh, John U. Doherty, John W. Eikelboom, Roberta Florido, William J. Hucker, Roxana Mehran, Steven Russell Messe et al. · 2017 · Journal of the American College of Cardiology
  59. Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation
    Ken Okumura, Masaharu Akao, Tetsuro Yoshida, Masahito Kawata, Osamu Okazaki, Shintaro Akashi, Kenichi Eshima, Kimihiko Tanizawa, Masayuki Fukuzawa, Takuya Hayashi et al. · 2020 · New England Journal of Medicine
  60. Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin
    Hylek, Elaine M., Held, Claes, Alexander, John H., Lopes, Renato D., De Caterina, Raffaele, Wojdyla, Daniel M., Huber, Kurt, Jansky, Petr, Steg, Philippe Gabriel, Hanna, Michael et al. · 2014 · Journal of the American College of Cardiology
  61. Cardiohepatic Interactions in Heart Failure
    Marc D. Samsky, Chetan B. Patel, Tracy A. DeWald, Alastair D. Smith, Gary Michael Felker, Joseph G. Rogers, Adrian F. Hernandez · 2013 · Journal of the American College of Cardiology
  62. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures
    György Frendl, Alissa Sodickson, Mina K. Chung, Albert L. Waldo, Bernard John Gersh, James Edward Tisdale, Hugh G Calkins, Sary F. Aranki, Tsuyoshi Kaneko, Stephen D. Cassivi et al. · 2014 · Journal of Thoracic and Cardiovascular Surgery
  63. Atrial fibrillation
    Gregory Y.H. Lip, Hung‐Fat Tse, Deirdre A. Lane · 2011 · The Lancet
  64. Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment
    Allison Burnett, Charles Edward Mahan, Sara R. Vazquez, Lynn B. Oertel, David A. Garcia, Jack Ansell · 2016 · Journal of Thrombosis and Thrombolysis
  65. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
    Michael Glikson, Rafael Wolff, Gerhard Hindricks, John M. Mandrola, Alan John Camm, Gregory Y.H. Lip, Laurent Fauchier, Timothy R. Betts, Thorsten Lewalter, Jacqueline Saw et al. · 2019 · EP Europace
  66. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
    Jonathan Paul Piccini, Valeria Caso, Stuart J. Connolly, Keith A.A. Fox, Jonas Oldgren, W. Schuyler Jones, Diana Adrienne Gorog, Václav Durdil, Thomas Viethen, Christoph Neumann et al. · 2022 · The Lancet
  67. Intracranial Hemorrhage
    J. Caceres, Joshua Norkin Goldstein · 2012 · Emergency Medicine Clinics of North America
  68. Screening to identify unknown atrial fibrillation: A systematic review
    Lowres, Nicole, Neubeck, Lis, Redfern, Julie, Freedman, S. Ben · 2013 · Thrombosis and Haemostasis
  69. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian Clinical Guidelines for the Diagnosis and Management of Atrial Fibrillation 2018
    David B. Brieger, John V. Amerena, John Attia, Beata V. Bajorek, Kim Hoe Chan, Cia Connell, Ben Freedman, Caleb Ferguson, Tanya L Hall, Haris M. Haqqani et al. · 2018 · Heart Lung and Circulation
  70. Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study
    Ammar Majeed, Anna Ågren, Margareta Holmström, Maria Bruzelius, Roza Chaireti, Jacob Odeberg, Eva-Lotta Hempel, Maria Magnusson, Tony Frisk, Sam Schulman · 2017 · Blood
  71. Distribution and Risk Profile of Paroxysmal, Persistent, and Permanent Atrial Fibrillation in Routine Clinical Practice: Insight From the Real-Life Global Survey Evaluating Patients With Atrial Fibrillation International Registry
    Chiang, Chern-En, Naditch-Brûlé, Lisa, Murin, Jan, Goethals, Marnix, Inoue, Hiroshi, O’Neill, James, Silva-Cardoso, Jose, Zharinov, Oleg, Gamra, Habib, Alam, Samir et al. · 2012 · Circulation: Arrhythmia and Electrophysiology
  72. The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis
    Chatree Chai‐Adisaksopha, Mark Andrew Crowther, Tetsuya Isayama, Wendy Lim · 2014 · Blood
  73. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion
    Bernhard Meier, Yuri Blaauw, Ahmed Aziz Khattab, Torsten Lewalter, Horst Sievert, Claudio Tondo, Michael Glikson, ESC Scientific Document Group, Gregory Y.H. Lip, José Ramón López-Mínguez et al. · 2014 · EP Europace
  74. Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients
    Gregory Y.H. Lip, Allison V. Keshishian, Xiaoyan Li, Melissa Hamilton, Cristina Masseria, Kiran B. Gupta, Xuemei Luo, Jack Mardekian, Keith E. Friend, Anagha Nadkarni et al. · 2018 · Stroke
  75. Gender differences in the effects of cardiovascular drugs
    Juan Luis Tamargo, Giuseppe M.C. Rosano, Thomas Walther, Juan Duarte, Alexander Niessner, JC Kaski, Claudio Ceconi, Heinz Drexel, Keld P. Kjeldsen, Gianluigi Savarese et al. · 2016 · European Heart Journal - Cardiovascular Pharmacotherapy
  76. Risk of ischaemic stroke according to pattern of atrial fibrillation: analysis of 6563 aspirin-treated patients in ACTIVE-A and AVERROES
    Vanassche, T., Lauw, M. N., Eikelboom, J. W., Healey, J. S., Hart, R. G., Alings, M., Avezum, A., Diaz, R., Hohnloser, S. H., Lewis, B. S. et al. · 2015 · European Heart Journal
  77. Causes of Death and Influencing Factors in Patients With Atrial Fibrillation: A Competing-Risk Analysis From the Randomized Evaluation of Long-Term Anticoagulant Therapy Study
    Marijon, Eloi, Le Heuzey, Jean-Yves, Connolly, Stuart, Yang, Sean, Pogue, Janice, Brueckmann, Martina, Eikelboom, John, Themeles, Ellison, Ezekowitz, Michael, Wallentin, Lars et al. · 2013 · Circulation
  78. Deep neural networks can predict new-onset atrial fibrillation from the 12-lead ECG and help identify those at risk of atrial fibrillation-related stroke
    Raghunath, Sushravya, Pfeifer, John M., Ulloa-Cerna, Alvaro E., Nemani, Arun, Carbonati, Tanner, Jing, Linyuan, vanMaanen, David P., Hartzel, Dustin N., Ruhl, Jeffery A., Lagerman, Braxton F. et al. · 2021 · Circulation
  79. Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation
    Lars C. Wallentin, Ziad Hijazi, Ulrika Andersson, John Hunter Alexander, Raffaele De Caterina, Michael Hanna, John David Horowitz, Elaine M. Hylek, Renato D. Lópes, Signild Åsberg et al. · 2014 · Circulation
  80. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex
    Anthony Carnicelli, Hwanhee Hong, Stuart J. Connolly, John W. Eikelboom, Robert Patrick Giugliano, David A. Morrow, Manesh R. Patel, Lars C. Wallentin, John Hunter Alexander, Maria Cecilia Bahit et al. · 2022 · Archive ouverte UNIGE (University of Geneva)
  81. 2024 European Heart Rhythm Association/Heart Rhythm Society/Asia Pacific Heart Rhythm Society/Latin American Heart Rhythm Society expert consensus statement on catheter and surgical ablation of atrial fibrillation
    Stylianos E. Tzeis, Edward P. Gerstenfeld, Jonathan M. Kalman, Eduardo Saad, Alireza Sepehri Shamloo, Jason G. Andrade, Chirag R. Barbhaiya, Tina Baykaner, Serge Bovéda, Hugh G Calkins et al. · 2024 · Heart Rhythm
  82. Cardiovascular Research Using the Korean National Health Information Database
    Eue‐Keun Choi · 2020 · Korean Circulation Journal
  83. Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a ‘real world’ atrial fibrillation population: A modelling analysis based on a nationwide cohort study
    Amitava Banerjee, Deirdre A. Lane, Christian Tobias Torp-Pedersen, Gregory Y.H. Lip · 2011 · Thrombosis and Haemostasis
  84. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines
    Andrew Veitch, Geoffroy Vanbiervliet, Anthony Gershlick, Christian Boustière, Trevor P Baglin, Lesley‐Ann Smith, Franco Radaelli, Evelyn Knight, Ian Mark Gralnek, Cesare Hassan et al. · 2016 · Gut
  85. Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society
    Cecilia Marianne Linde, Maria Grazia Bongiorni, Ulrika Maria Birgersdotter-Green, Anne B. Curtis, Isabel Deisenhofer, Tetsushi Furokawa, Anne M. Gillis, Kristina Hermann Haugaa, Gregory Y.H. Lip, Isabelle C. Van Gelder et al. · 2018 · EP Europace
  86. Incidence of Atrial Fibrillation and Relationship With Cardiovascular Events, Heart Failure, and Mortality
    Vermond, Rob A., Geelhoed, Bastiaan, Verweij, Niek, Tieleman, Robert G., Van der Harst, Pim, Hillege, Hans L., Van Gilst, Wiek H., Van Gelder, Isabelle C., Rienstra, Michiel · 2015 · Journal of the American College of Cardiology
  87. Rationale and design of the Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation (ARTESiA) trial
    Renato D. Lópes, Marco Alings, Stuart J. Connolly, Heather Beresh, Christopher Bull Granger, Juan Benezet Mazuecos, Giuseppe Boriani, Jens Cosedis Nielsen, David Conen, Stefan Hans Hohnloser et al. · 2017 · American Heart Journal
  88. Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
    Mintu P. Turakhia, Peter J. Blankestijn, Juan Jesús Carrero, Catherine M. Clase, Rajat Deo, Charles A. Herzog, Scott Eric Kasner, ROD S. PASSMAN, Roberto Pecoits‐Filho, Holger Reinecke et al. · 2018 · European Heart Journal
  89. Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve
    Hélio Penna Guimarães, Renato D. Lópes, Pedro Gabriel Melo de Barros e Silva, Idelzuita Leandro Liporace, Roney Orismar Sampaio, Flávio Tarasoutchi, Conrado Roberto Hoffmann Filho, Rodrigo de Lemos Soares Patriota, Tiago Luiz Luz Leiria, Diana Lamprea et al. · 2020 · New England Journal of Medicine
  90. Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor<scp>X</scp>a inhibitor, in healthy subjects
    Frost, Charles, Nepal, Sunil, Wang, Jessie, Schuster, Alan, Byon, Wonkyung, Boyd, Rebecca A., Yu, Zhigang, Shenker, Andrew, Barrett, Yu Chen, Mosqueda‐Garcia, Rogelio et al. · 2013 · British Journal of Clinical Pharmacology
  91. Indirect Comparisons of New Oral Anticoagulant Drugs for Efficacy and Safety When Used for Stroke Prevention in Atrial Fibrillation
    Gregory Y.H. Lip, Torben Bjerregaard Larsen, Flemming Skjøth, Lars Hvilsted Rasmussen · 2012 · Journal of the American College of Cardiology
  92. 2013 ACCF/AHA Guideline for the Management of Heart Failure: Executive Summary
    Clyde W. Yancy, Mariell L Jessup, Biykem Bozkurt, Javed Butler, Donald E. Casey, Mark H. Drazner, Gregg C. Fonarow, Stephen A. Geraci, Tamara B. Horwich, James L. Januzzi et al. · 2013 · Journal of the American College of Cardiology
  93. Pharmacology of antithrombotic drugs: an assessment of oral antiplatelet and anticoagulant treatments
    Jessica L. Mega, Tabassome Simon · 2015 · The Lancet
  94. Stroke prevention in atrial fibrillation: An Asian perspective
    Kang-Ling Wang, Gregory Y.H. Lip, Chern‐En Chiang · 2014 · Thrombosis and Haemostasis
  95. Pharmacokinetics, pharmacodynamics, and safety of apixaban in subjects with end‐stage renal disease on hemodialysis
    Xiaoli Wang, Giridhar Tirucherai, Thomas C Marbury, Jessie J.J. Wang, Ming Chang, Donglu Zhang, Yan Jun Song, Janice M. Pursley, Rebecca A. Boyd, Charles E. Frost · 2015 · The Journal of Clinical Pharmacology
  96. Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study
    Jeff S. Healey, Jonas Oldgren, Michael D. Ezekowitz, Jun Zhu, Prem Pais, Jia Wang, Patrick Commerford, Petr Janský, Álvaro Avezum, Alben Sigamani et al. · 2016 · The Lancet
  97. Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial
    J. Donald Easton, Renato D. Lópes, Maria Cecilia Bahit, DANIEL M. WOJDYLA, Christopher Bull Granger, Lars C. Wallentin, Marco Alings, Shinya Goto, Basil S. Lewis, Mårten Rosenqvist et al. · 2012 · The Lancet Neurology
  98. Bleeding risk assessment and management in atrial fibrillation patients
    Laurent Fauchier, Elaine M. Hylek, Eve Knight, Deirdre A. Lane, Marcel M Levi, Francisco R. Marín, Gualtiero Palareti, Collet Jp, Andrea Rubboli, Daniela Poli et al. · 2011 · Thrombosis and Haemostasis
  99. Ibrutinib‐associated bleeding: pathogenesis, management and risk reduction strategies
    Joseph James Shatzel, Samuel R. Olson, D.L. Tao, Owen J. T. McCarty, Alexey Valeryevich Danilov, Thomas G. DeLoughery · 2017 · Journal of Thrombosis and Haemostasis
  100. The Changing Landscape for Stroke Prevention in AF
    Menno Volkert Huisman, Kenneth Jay Rothman, Miney Paquette, Christine Teutsch, Hans‐Christoph Diener, Sérgio Dubner, Jonathan L. Halperin, Chang Sheng, Kristina Zint, Amelie Elsaesser et al. · 2017 · Journal of the American College of Cardiology